Your browser doesn't support javascript.
loading
Dominant-negative heterozygous mutations in AIRE confer diverse autoimmune phenotypes.
Oftedal, Bergithe E; Assing, Kristian; Baris, Safa; Safgren, Stephanie L; Johansen, Isik S; Jakobsen, Marianne Antonius; Babovic-Vuksanovic, Dusica; Agre, Katherine; Klee, Eric W; Majcic, Emina; Ferré, Elise M N; Schmitt, Monica M; DiMaggio, Tom; Rosen, Lindsey B; Rahman, Muhammad Obaidur; Chrysis, Dionisios; Giannakopoulos, Aristeidis; Garcia, Maria Tallon; González-Granado, Luis Ignacio; Stanley, Katherine; Galant-Swafford, Jessica; Suwannarat, Pim; Meyts, Isabelle; Lionakis, Michail S; Husebye, Eystein S.
Afiliação
  • Oftedal BE; Department of Clinical Science, University of Bergen and Department of Medicine, Haukeland University Hospital, Bergen, Norway.
  • Assing K; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
  • Baris S; Marmara University, Faculty of Medicine, Pediatric Allergy and Immunology, Istanbul, Turkey.
  • Safgren SL; Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Istanbul, Turkey.
  • Johansen IS; Center for Individualized Medicine, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Jakobsen MA; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
  • Babovic-Vuksanovic D; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
  • Agre K; Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.
  • Klee EW; Invitae, San Francisco, CA, USA.
  • Majcic E; Mayo Clinic, Department of Quantitative Health Sciences, Rochester, MN, USA.
  • Ferré EMN; Department of Clinical Science, University of Bergen and Department of Medicine, Haukeland University Hospital, Bergen, Norway.
  • Schmitt MM; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • DiMaggio T; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Rosen LB; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Rahman MO; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Chrysis D; Department of Clinical Science, University of Bergen and Department of Medicine, Haukeland University Hospital, Bergen, Norway.
  • Giannakopoulos A; Department of Pediatrics, Division of Pediatric Endocrinology, Medical School, University of Patras, Rion, Greece.
  • Garcia MT; Department of Pediatrics, Division of Pediatric Endocrinology, Medical School, University of Patras, Rion, Greece.
  • González-Granado LI; Pediatric Hematology and Oncology Department, Hospital Álvaro Cunqueiro, Vigo, Spain.
  • Stanley K; Unidad de Inmunodeficiencias, Pediatría, Instituto de Investigación Hospital 12 de Octubre, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
  • Galant-Swafford J; Mid-Atlantic Permanente Medical Group, Kaiser Permanente MidAtlantic, Rockville, MD, USA.
  • Suwannarat P; Division of Allergy & Clinical Immunology, National Jewish Health, Denver, CO, USA.
  • Meyts I; Mid-Atlantic Permanente Medical Group, Kaiser Permanente MidAtlantic, Rockville, MD, USA.
  • Lionakis MS; Department of Pediatrics, University Hospital Leuven, Laboratory for Inborn Errors of Immunity, Department of Microbiology Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Husebye ES; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
iScience ; 26(6): 106818, 2023 Jun 16.
Article em En | MEDLINE | ID: mdl-37235056
Autoimmune polyendocrine syndrome type 1 (APS-1) is an autosomal recessive disease characterized by severe and childhood onset organ-specific autoimmunity caused by mutations in the autoimmune regulator (AIRE) gene. More recently, dominant-negative mutations within the PHD1, PHD2, and SAND domains have been associated with an incompletely penetrant milder phenotype with later onset familial clustering, often masquerading as organ-specific autoimmunity. Patients with immunodeficiencies or autoimmunity where genetic analyses revealed heterozygous AIRE mutations were included in the study and the dominant-negative effects of the AIRE mutations were functionally assessed in vitro. We here report additional families with phenotypes ranging from immunodeficiency, enteropathy, and vitiligo to asymptomatic carrier status. APS-1-specific autoantibodies can hint to the presence of these pathogenic AIRE variants although their absence does not rule out their presence. Our findings suggest functional studies of heterozygous AIRE variants and close follow-up of identified individuals and their families.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article